Recipharm invests $750k in new GMP suite

By Melissa Fassbender contact

- Last updated on GMT

The suite during an MDI manufacturing process. (Image: Recipharm)
The suite during an MDI manufacturing process. (Image: Recipharm)

Related tags: Research triangle park

Recipharm has opened a new GMP suite for clinical trial material manufacture at its North Carolina-based facility in Research Triangle Park.

The new suite enables the contract development and manufacturing organization (CDMO) to provide complete early development services at the Research Triangle Park location. These services include process development and scale-up, CTM manufacturing and packaging, product release and stability programs.

Ann Flodin, VP and General Manager at Recipharm Laboratories, explained the facility supports the manufacture of different non-sterile dosage forms, such as metered dose inhalers, semi-solids, and dry powder capsules.  

With this location being Recipharm’s center of excellence for orally inhaled and nasal drug products, and with an experienced research team in place, this is a natural development for the company, extending the capabilities of Recipharm group​,” Flodin told

The GMP suite is ISO 8 certified, features a walk-in downflow booth, and has the capacity to produce metered dose inhalers in up to 25L batches and offers semi-solid production capabilities up to 20L.

We see the inhalation and semi-solid industries growing, and needing additional clinical trial manufacturing support," ​Flodin added.

"Also, the location is central in Research Triangle Park which is a rapidly growing science and technology cluster, with easy access for visitors through the nearby RDU airport​.”

Related news

Show more

Related products

Innovations in OSD

Innovations in OSD

Recorded the 06-Oct-2020 | Webinar

This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more